Sulforaphane potentiates the efficacy of chemoradiotherapy in glioblastoma by selectively targeting thioredoxin reductase 1.
Ge Y, Ge Z, Tian F, Tai X, Chen D, Sun S, Shi Z, Yin J, Wei G, Li D, Wang L, Xu W, Tong M, Liu F, Zhao L, Qian X, Ge X.
Ge Y, et al. Among authors: zhao l.
Cancer Lett. 2024 Dec 24:217429. doi: 10.1016/j.canlet.2024.217429. Online ahead of print.
Cancer Lett. 2024.
PMID: 39725145